Liang Dong

Title: **The Innovative Mind of Liang Dong: Advancements in Controlled Release Formulations**

Introduction

Liang Dong, an accomplished inventor based in Hayward, CA, holds an impressive portfolio of 14 patents that significantly contribute to the field of pharmaceuticals. His work primarily focuses on creating innovative drug formulations, emphasizing controlled-release mechanisms that enhance therapeutic effectiveness.

Latest Patents

Among his latest groundbreaking inventions are the muco-adhesive, controlled-release formulations of levodopa and/or its esters. These formulations involve a sophisticated assembly that includes controlled release components with a core of levodopa and immediate-release components also containing the same active ingredient. Notably, these inventions incorporate a decarboxylase inhibitor, with the controlled-release components being mostly free of this inhibitor. This innovative approach is designed to improve patient outcomes by providing an optimized delivery system for levodopa therapies.

Career Highlights

Currently, Liang Dong is a vital member of Impax Laboratories, Inc., where he plays a significant role in advancing pharmaceutical technologies. His contributions have positioned him as a key innovator in the development of formulations that benefit patients with specific medical needs.

Collaborations

Throughout his career, Liang has collaborated closely with talented colleagues, including Ann Hsu and Amy Ding. These partnerships have fostered an environment of creativity and innovation, driving the development of novel therapeutic solutions.

Conclusion

Liang Dong's work exemplifies the impact of innovation in the pharmaceutical industry. With a focus on controlled-release formulations, he continues to push the boundaries of drug delivery systems, ensuring improved therapeutic outcomes for patients. His extensive patent portfolio reflects his dedication to advancing medical science through inventive solutions.